the-infoshop.com - The vertical markets research portal

View Cart

Global Information, Inc.
US:	+1-860-674-8796
EU:	+32-2-535-7543
SG:	+65-6223-2436

|

|

|

Custom Research

|

About The Infoshop

|

|

|

Bone Disease Treatment

Feminine Hygiene

Gastrointestinal

Hepatitis

In Vitro Diagnostics(IVD)

Infection Disease

Neurodegenerative Disease

Obesity Treatment

Pharmaceutical Companies

Prescription Drugs

Therapeutics /Diagnosis

Veterinary Medicine

View All Categories

Hepatitis Market Research, Trends, and Analysis


	Global Information, Inc. offers market intelligence on every topic in the Hepatitis Treatment Industry, including, but not limited to: Gastroenterology, Infectious Hepatitis, Virus, Hepatitis B and Hepatitis C and Vaccines. We offer market research, industry forecasts, and business analysis in the Hepatitis Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

Reports

Stakeholder Opinions: Hepatitis C - Small-molecule antivirals pave the way for triple therapy
Published : 2007/12
This report provides Hepatitis C Stakeholder Opinions Market Research, Trends, Analysis. ...

Stakeholder Opinions: Multiple Myeloma - Exploring new targets for multiple drug therapy
Published : 2007/12
This report provides Multiple Myeloma Stakeholder Opinions Market Research, Trends, Analysis. ...

Commercial and Pipeline Insight: Hepatitis B - Improved antivirals drive rapid market growth
Published : 2007/10
This report analyses the impact of existing and developmental antivirals and vaccines on the market and its long-term potential. ...

Global Hepatitis Strategies
Published : 2007/08
The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. ...

Over the Counter Diagnostic Product World Markets
Published : 2006/09
The purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. ...

New Drug Futures: Anti-Infectives
Published : 2006/05
This chapter of New Drug Futures evaluates, compares and contrasts the prospects for the compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond in the anti-infective sector. ...

The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition
Published : 2006/04
This completely updated edition of Kalorama's comprehensive and indispensable report covers the breadth of traditional IVD testing. ...

U.S. Infectious Disease Diagnostics Markets
Published : 2006/04
The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. ...

HIV: A Strategic Analysis of Therapeutic and Testing Markets
Published : 2006/03
The strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in a ...

The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
Published : 2006/03
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size ...

Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
Published : 2006/02
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the ...

Global Vaccines Markets
Published : 2006/01
Global Vaccine Manufacturers Need to Scale up Operations in Emerging Countries to Solve Issues of Supply and Demand ...

Strategic Analysis of the U.S. Hepatitis B and C Markets
Published : 2006/01
Hepatitis B and C Markets provides strategic recommendations and SWOT analysis, patient and pricing forecasts, market share analysis, and analysis of existing and new products. ...

Schering-Plough: PharmaVitae Profile 2005
Published : 2005/12
This analysis examines the current position and future outlook for Schering-Plough in the ethical pharmaceutical sector. ...

Stakeholder Insight: Hepatitis in China - Liver Let Die?
Published : 2005/12
Hepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally. ...

Molecular Diagnostics: New Growth, New Markets
Published : 2005/11
Molecular Diagnostics: New Growth, New Markets highlights current trends in the molecular diagnostic industry and the major prospects and challenges ahead. ...

Stakeholder Opinions: Sexually Transmitted Infections - The Silent Menace
Published : 2005/11
The global incidence of STIs is estimated at several hundreds of millions cases per year, and due to the asymptomatic nature of most infections, underreporting is likely to mask the real incidence. ...

PharmaVitae 2005: GlaxoSmithKline Global Analysis
Published : 2005/10
This analysis examines the current position and future outlook for GSK in the ethical pharmaceutical sector. ...

PharmaVitae 2005: GlaxoSmithKline Global and US Analysis
Published : 2005/10
This analysis examines the current position and future outlook for GSK in the ethical pharmaceutical sector. ...

Stakeholder Insight: HIV - A way of life
Published : 2005/10
HIV is now considered a chronic, manageable disease. ...

Dynamic Antibody Industry
Published : 2005/08
Monoclonal antibody drugs offer several advantages over other types of drugs. Technologically, antibodies exhibit amazing specificity that allows for a safe and targeted attack on disease-causing cells or compounds. ...